T. Jared Bunch, MD

Journal Article

1. Feuerborn M, Torre M, Lyons A, Bunch TJ, Steinberg B (2024). Real-Time Ambulatory ECG Does Not Expedite Care. Journal of the American Heart Association, 13(21), e036520.
2. Reynolds MR, Bunch TJ, Steinberg BA, Ronk CJ, Kim H, Wieloch M, Lip GY (2023). Novel methodology for the evaluation of symptoms reported by patients with newly diagnosed atrial fibrillation: Application of natural language processing to electronic medical records data. Journal of cardiovascular electrophysiology, 34(4), 790-799.
3. Steinberg BA, Li Z, Shrader P, Chew DS, Bunch TJ, Mark DB, Nabutovsky Y, Shah RU, Greiner MA, Piccini J (2022). Bimodal distribution of atrial fibrillation burden in 3 distinct cohorts: What is 'paroxysmal' atrial fibrillation?. American heart journal, 244, 149-156.
4. Baykaner T, Pundi K, Lin B, Lu Y, DeSutter K, Lhamo K, Garay G, Nunes JC, Morin DP, Sears SF, Chung MK, Paasche-Orlow MK, Sanders LM, Bunch TJ, Hills MT, Mahaffey KW, Stafford RS, Wang P (2022). The ENHANCE-AF Clinical Trial to Evaluate an Atrial Fibrillation Shared Decision-Making Pathway: Rationale and Study Design. American heart journal,
5. Bunch TJ, May H, Cutler M, Woller SC, Jacobs V, Stevens SM, Carlquist J, Knowlton KU, Muhlestein JB, Steinberg BA, Anderson J (2022). Impact of anticoagulation therapy on the cognitive decline and dementia in patients with non-valvular atrial fibrillation (cognitive decline and dementia in patients with non-valvular atrial fibrillation [CAF] trial). Journal of arrhythmia, 38(6), 997-1008.
6. Chew DS, Li Z, Steinberg BA, O'Brien E, Pritchard J, Bunch TJ, Mark DB, Patel MR, Nabutovsky Y, Greiner MA, Piccini J (2021). Association between Economic and Arrhythmic Burden of Paroxysmal Atrial Fibrillation in Patients with Cardiac Implanted Electronic Devices. American heart journal, 244, 116-124.
7. Burnham TS, May HT, Bair TL, Anderson JA, Crandall BG, Cutler MJ, Day JD, Freedman RA, Knowlton KU, Muhlestein JB, Navaravong L, Ranjan RA, Steinberg BA, Bunch T (2021). Long-term outcomes in patients treated with flecainide for atrial fibrillation with stable coronary artery disease. American heart journal, 243, 127-139.
8. Rizzi SA, Knight S, May HT, Woller SC, Stevens SM, Steinberg BA, Bair TL, Anderson JL, Muhlestein JB, Knowlton KU, Bunch T (2021). Depression as a Driving Force for Low Time in Therapeutic Range and Dementia in Patients With and Without Atrial Fibrillation. The American journal of cardiology, 153, 58-64.
9. Aguilar M, Tedrow UB, Tzou WS, Tung R, Frankel DS, Santangeli P, Vaseghi M, Bunch TJ, Di Biase L, Tholakanahalli VN, Lakkireddy D, Dickfeld T, Weiss JP, Mathuria N, Vergara P, Nakahara S, Bradfield JS, Burkhardt JD, Stevenson WG, Callans DJ, Della Bella P, Natale A, Shivkumar K, Marchlinski FE, Sauer W (2021). Catheter ablation of ventricular tachycardia in patients with prior cardiac surgery: An analysis from the International VT Ablation Center Collaborative Group. Journal of cardiovascular electrophysiology, 32(2), 409-416.
10. Kewcharoen J, Techorueangwiwat C, Kanitsoraphan C, Leesutipornchai T, Akoum N, Bunch TJ, Navaravong (2021). High-power short duration and low-power long duration in atrial fibrillation ablation: A meta-analysis. Journal of cardiovascular electrophysiology, 32(1), 71-82.
11. Kanitsoraphan C, Techorueangwiwat C, Rattanawong P, Kewcharoen J, Ayinapudi K, Bunch TJ, Groh C, Navaravong (2021). Zero fluoroscopy approach versus fluoroscopy approach for cardiac arrhythmia ablations: A systematic review and meta-analysis. Journal of cardiovascular electrophysiology, 32(10), 2761-2776.
12. Martinez MW, Kim JH, Shah AB, Phelan D, Emery MS, Wasfy MM, Fernandez AB, Bunch TJ, Dean P, Danielian A, Krishnan S, Baggish AL, Eijsvogels TMH, Chung EH, Levine B (2021). Exercise-Induced Cardiovascular Adaptations and Approach to Exercise and Cardiovascular Disease: JACC State-of-the-Art Review. Journal of the American College of Cardiology, 78(14), 1453-1470.
13. Basu-Ray I, Khanra D, Shah SK, Mukherjee A, Char SV, Jain B, Bunch TJ, Gold M, Adeboye AA, Saeed (2021). Meta-analysis comparing outcomes of catheter ablation for ventricular arrhythmia in ischemic versus nonischemic cardiomyopathy. Pacing and clinical electrophysiology, 44(1), 54-62.
14. Steinberg BA, Zhang M, Bensch J, Lyons A, Bunch TJ, Piccini JP, Siu A, Spertus JA, Stehlik J, Wohlfahrt P, Greene T, Hess R, Fang J (2021). Quantifying the Impact of Atrial Fibrillation on Heart Failure-Related Patient-Reported Outcomes in the Utah mEVAL Program. Journal of cardiac failure, 28, 13-20.
15. Kewcharoen J, Vutthikraivit W, Rattanawong P, Prasitlumkum N, Akoum NW, Bunch TJ, Navaravong (2021). Renal sympathetic denervation in addition to pulmonary vein isolation reduces the recurrence rate of atrial fibrillation: an updated meta-analysis of randomized control trials. Journal of interventional cardiac electrophysiology, 60(3), 459-467.
16. Duncker D, Ding WY, Etheridge S, Noseworthy PA, Veltmann C, Yao X, Bunch TJ, Gupta (2021). Smart Wearables for Cardiac Monitoring-Real-World Use beyond Atrial Fibrillation. Sensors (Basel, Switzerland), 21(7),
17. Steinberg BA, Li Z, O'Brien EC, Pritchard J, Chew DS, Bunch TJ, Mark DB, Nabutovsky Y, Greiner MA, Piccini J (2021). Atrial fibrillation burden and heart failure: Data from 39,710 individuals with cardiac implanted electronic devices. Heart rhythm, 18(5), 709-716.
18. Gakenheimer-Smith L, Meyers L, Lundahl D, Menon SC, Bunch TJ, Sawyer BL, Tristani-Firouzi M, Etheridge S (2021). Expanding the phenotype of CACNA1C mutation disorders. Molecular genetics & genomic medicine, 9(6), e1673.
19. Turner JL, Steinberg BA, Bunch TJ, Ranjan (2021). Inflammatory cutaneous reaction to a temporary permanent pacemaker. HeartRhythm case reports, 7(8), 571-572.
20. Kamali R, Kump J, Ghafoori E, Lange M, Hu N, Bunch TJ, Dosdall DJ, Macleod RS, Ranjan (2021). Area Available for Atrial Fibrillation to Propagate Is an Important Determinant of Recurrence After Ablation. JACC. Clinical electrophysiology, 7(7), 896-908.
21. Burnham TS, Scott ML, Steinberg BA, Varela DL, Zenger B, Bunch T (2021). Impact of Catheter Ablation on Stroke, Cognitive Decline and Dementia. Arrhythmia & electrophysiology review, 10(3), 205-210.
22. Kewcharoen J, Prasitlumkum N, Chokesuwattanaskul R, Yi R, Jongnarangsin K, Bunch TJ, Ranjan R, Navaravong (2021). Ablation versus medication as initial therapy for paroxysmal atrial fibrillation: An updated meta-analysis of randomized controlled trials. Journal of arrhythmia, 37(6), 1448-1458.
23. Basu-Ray I, Khanra D, Kupó P, Bunch J, Theus SA, Mukherjee A, Shah SK, Komócsi A, Adeboye A, Jefferies (2021). Outcomes of uninterrupted vs interrupted Periprocedural direct oral Anticoagulants in atrial Fibrillation ablation: A meta-analysis. Journal of arrhythmia, 37(2), 384-393.
24. Anderson JL, Knight S, McCubrey RO, May HT, Mason S, Bunch TJ, Min DB, Cutler MJ, Le VT, Muhlestein JB, Knowlton K (2021). Absent or Mild Coronary Calcium Predicts Low-Risk Stress Test Results and Outcomes in Patients Considered for Flecainide Therapy. Journal of cardiovascular pharmacology and therapeutics, 26(6), 648-655.
25. Muhlestein JB, Anderson JL, Bethea CF, Severance HW, Mentz RJ, Barsness GW, Barbagelata A, Albert D, Le VT, Bunch TJ, Yanowitz F, May HT, Chisum B, Ronnow BS, Muhlestein JB, Duke University Cooperative Cardiovascular Society (DUCCS) investigators (2020). Feasibility of combining serial smartphone single-lead electrocardiograms for the diagnosis of ST-elevation myocardial infarction. American heart journal, 221, 125-135.
26. Anderson JL, Jacobs V, May HT, Bair TL, Benowitz BA, Lappe DL, Muhlestein JB, Knowlton KU, Bunch T (2020). Free thyroxine within the normal reference range predicts risk of atrial fibrillation. Journal of cardiovascular electrophysiology, 31(1), 18-29.
27. Zenger B, Zhang M, Lyons A, Bunch TJ, Fang JC, Freedman RA, Navaravong L, Piccini JP, Ranjan R, Spertus JA, Stehlik J, Turner JL, Greene T, Hess R, Steinberg B (2020). Patient-reported outcomes and subsequent management in atrial fibrillation clinical practice: Results from the Utah mEVAL AF program. Journal of cardiovascular electrophysiology, 31(12), 3187-3195.
28. Bunch T (2020). Atrial Fibrillation and Dementia. Circulation, 142(7), 618-620.
29. Sepehri Shamloo A, Bunch TJ, Lin YJ, de Oliveira Figueiredo MJ, Dagres N, Nielsen J (2020). Risk Assessment in Cardiac Arrhythmias. European heart journal, 41(47), 4455-4457.
30. Piccini JP Sr,, Allred J, Bunch TJ, Deering TF, Di Biase L, Hussein AA, Lewis WR, Mittal S, Natale A, Osorio J, Packer DL, Ruff C, Russo AM, Sanders P, Seiler A, Slotwiner D, Hills MT, Turakhia MP, Van Gelder IC, Varosy PD, Verma A, Volgman AS, Wood KA, Deneke (2020). Rationale, considerations, and goals for atrial fibrillation centers of excellence: A Heart Rhythm Society perspective. Heart rhythm, 17(10), 1804-1832.
31. Bunch TJ, Bair TL, Crandall BG, Cutler MJ, Day JD, Graves KG, Jacobs V, Mallender C, Osborn JS, Weiss JP, May H (2020). Stroke and dementia risk in patients with and without atrial fibrillation and carotid arterial disease. Heart rhythm, 17(1), 20-26.
32. Proietti R, AlTurki A, Vio R, Licchelli L, Rivezzi F, Marafi M, Russo V, Potpara TS, Kalman JM, de Villers-Sidani E, Bunch T (2020). The association between atrial fibrillation and Alzheimer's disease: fact or fallacy? A systematic review and meta-analysis. Journal of cardiovascular medicine (Hagerstown, Md.), 21(2), 106-112.
33. Zenger B, Swink JM, Turner JL, Bunch TJ, Ryan JJ, Shah RU, Turakhia MP, Piccini JP, Steinberg B (2020). Social Media Influence Does Not Reflect Scholarly or Clinical Activity in Real Life. Circulation. Arrhythmia and electrophysiology, 13(11), e008847.
34. Bunch T (2019). Too much, too little, or just right?: Applying the Goldilocks principle to cryoballoon ablation for atrial fibrillation. Journal of cardiovascular electrophysiology, 30(1), 25-26.
35. Horne BD, Jacobs V, May HT, Graves KG, Bunch T (2019). Augmented intelligence decision tool for stroke prediction combines factors from CHA2 DS2 -VASc and the intermountain risk score for patients with atrial fibrillation. Journal of cardiovascular electrophysiology, 30(9), 1452-1461.
36. Bunch TJ, May HT, Afshar K, Alharethi R, Day J (2019). Mechanisms of Improved Mortality Following Ablation: Does Ablation Restore Beta-Blocker Benefit in Atrial Fibrillation/Heart Failure?. Cardiology clinics, 37(2), 177-183.
37. Bunch TJ, Jacobs V, May H, Stevens SM, Crandall B, Cutler M, Day JD, Mallender C, Olson J, Osborn J, Weiss JP, Woller S (2019). Rationale and design of the impact of anticoagulation therapy on the Cognitive Decline and Dementia in Patients with Nonvalvular Atrial Fibrillation (CAF) Trial: A Vanguard study. Clinical cardiology, 42(5), 506-512.
38. Packer DL, Mark DB, Robb RA, Monahan KH, Bahnson TD, Poole JE, Noseworthy PA, Rosenberg YD, Jeffries N, Mitchell LB, Flaker GC, Pokushalov E, Romanov A, Bunch TJ, Noelker G, Ardashev A, Revishvili A, Wilber DJ, Cappato R, Kuck KH, Hindricks G, Davies DW, Kowey PR, Naccarelli GV, Reiffel JA, Piccini JP, Silverstein AP, Al-Khalidi HR, Lee KL, CABANA Investigators (2019). Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial. JAMA, 321, 1261-1274.
39. Galenko O, Jacobs V, Knight S, Taylor M, Cutler MJ, Muhlestein JB, Carlquist JL, Knowlton KU, Jared Bunch (2019). The role of microRNAs in the development, regulation, and treatment of atrial fibrillation. Journal of interventional cardiac electrophysiology,
40. Turagam MK, Atoui M, Atkins D, Di Biase L, Shivkumar K, Jared Bunch T, Mohanty S, Gianni C, Natale A, Lakkireddy (2019). Persistent left superior vena cava as an arrhythmogenic source in atrial fibrillation: results from a multicenter experience. Journal of interventional cardiac electrophysiology, 54(2), 93-100.
41. Graves KG, May HT, Jacobs V, Knowlton KU, Muhlestein JB, Lappe DL, Anderson JL, Horne BD, Bunch T (2019). CHA2DS2-VASc scores and Intermountain Mortality Risk Scores for the joint risk stratification of dementia among patients with atrial fibrillation. Heart rhythm, 16(1), 3-9.
42. Saglietto A, Matta M, Gaita F, Jacobs V, Bunch TJ, Anselmino (2019). Stroke-independent contribution of atrial fibrillation to dementia: a meta-analysis. Open heart, 6(1), e000984.
43. Bunch TJ, Galenko O, Graves KG, Jacobs V, May H (2019). Atrial Fibrillation and Dementia: Exploring the Association, Defining Risks and Improving Outcomes. Arrhythmia & electrophysiology review, 8(1), 8-12.
44. Slotwiner DJ, Abraham RL, Al-Khatib SM, Anderson HV, Bunch TJ, Ferrara MG, Lippman N, Serwer GA, Steiner PR, Tcheng JE, Varma N, Wilkoff B (2019). HRS White Paper on interoperability of data from cardiac implantable electronic devices (CIEDs). Heart rhythm, 16(9), e107-e127.
45. Bunch T (2019). EP News: Case Reports. Heart rhythm,
46. Jacobs V, T May H, L Bair T, G Crandall B, J Cutler DO M, D Day J, Le V, Mallender C, S Osborn J, Weiss JP, Bunch T (2019). The Impact of Repeated Cardioversions for Atrial Fibrillation on Stroke, Hospitalizations, and Catheter Ablation Outcomes. Journal of atrial fibrillation, 11(6), 2164.
47. Mansour M, Heist EK, Agarwal R, Bunch TJ, Karst E, Ruskin JN, Mahapatra (2018). Stroke and Cardiovascular Events After Ablation or Antiarrhythmic Drugs for Treatment of Patients With Atrial Fibrillation. The American journal of cardiology, 121(10), 1192-1199.
48. Golive A, May HT, Bair TL, Jacobs V, Crandall BG, Cutler MJ, Day JD, Mallender C, Osborn JS, Weiss JP, Bunch T (2018). The Impact of Gender on Atrial Fibrillation Incidence and Progression to Dementia. The American journal of cardiology, 122(9), 1489-1495.
49. Bunch TJ, May HT, Bair TL, Crandall BG, Cutler MJ, Day JD, Jacobs V, Mallender C, Osborn JS, Weiss J (2018). Five-year impact of catheter ablation for atrial fibrillation in patients with a prior history of stroke. Journal of cardiovascular electrophysiology, 29(2), 221-226.
50. Turakhia MP, Blankestijn PJ, Carrero JJ, Clase CM, Deo R, Herzog CA, Kasner SE, Passman RS, Pecoits-Filho R, Reinecke H, Shroff GR, Zareba W, Cheung M, Wheeler DC, Winkelmayer WC, Wanner C, Conference Participant (2018). Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. European heart journal, 39(24), 2314-2325.
51. Toso E, Peyracchia M, Matta M, D'Ascenzo F, Gaita F, Kornej J, Hindricks G, Jared Bunch T, Saliba (2018). Incidence of thromboembolic events following atrial fibrillation catheter ablation and rate control strategies according to the kind of oral anticoagulation: A systematic review and meta-analysis. International journal of cardiology, 270, 172-179.
52. Tracy CM, Crossley GH, Bunch TJ, Chow GV, Leiserowitz A, Indik JH, Kusumoto F, Mendes LA, Munger TM, Murali S, Patton KK, Russo AM, Scheinman M, Schoenhard JA, Winterfield J (2018). 2017 ACC/HRS Lifelong Learning Statement for Clinical Cardiac Electrophysiology Specialists: A Report of the ACC Competency Management Committee. Journal of the American College of Cardiology, 71(2), 231-250.
53. Barbagelata A, Bethea CF, Severance HW, Mentz RJ, Albert D, Barsness GW, Le VT, Anderson JL, Bunch TJ, Yanowitz F, Chisum B, Ronnow BS, Muhlestein J (2018). Smartphone ECG for evaluation of ST-segment elevation myocardial infarction (STEMI): Design of the ST LEUIS International Multicenter Study. Journal of electrocardiology, 51(2), 260-264.
54. Jacobs V, May HT, Crandall BG, Ballantyne B, Chisum B, Johnson D, Graves KG, Cutler M, Day JD, Mallender C, Osborn JS, Weiss JP, Bunch T (2018). Vagus nerve injury symptoms after catheter ablation for atrial fibrillation. Pacing and clinical electrophysiology, 41(4), 389-395.
55. Graves KG, Jacobs V, May HT, Cutler MJ, Day JD, Bunch T (2018). Atrial Fibrillation Ablation and its Impact on Stroke. Current treatment options in cardiovascular medicine, 20(1), 2.
56. Vergara P, Tung R, Vaseghi M, Brombin C, Frankel DS, Di Biase L, Nagashima K, Tedrow U, Tzou WS, Sauer WH, Mathuria N, Nakahara S, Vakil K, Tholakanahalli V, Bunch TJ, Weiss JP, Dickfeld T, Vunnam R, Lakireddy D, Burkhardt JD, Correra A, Santangeli P, Callans D, Natale A, Marchlinski F, Stevenson WG, Shivkumar K, Della Bella (2018). Successful ventricular tachycardia ablation in patients with electrical storm reduces recurrences and improves survival. Heart rhythm, 15(1), 48-55.
57. Winterfield JR, Kent AR, Karst E, Dalal N, Mahapatra S, Bunch TJ, Reynolds MR, Wilber D (2018). Impact of ventricular tachycardia ablation on health care utilization. Heart rhythm, 15(3), 355-362.
58. Tracy CM, Crossley GH, Bunch TJ, Chow GV, Leiserowitz A, Indik JH, Kusumoto F, Mendes LA, Munger TM, Murali S, Patton KK, Russo AM, Scheinman M, Schoenhard JA, Winterfield J (2018). 2017 ACC/HRS lifelong learning statement for clinical cardiac electrophysiology specialists: A report of the ACC Competency Management Committee. Heart rhythm, 15(2), e17-e34.
59. Dagres N, Chao TF, Fenelon G, Aguinaga L, Benhayon D, Benjamin EJ, Bunch TJ, Chen LY, Chen SA, Darrieux F, de Paola A, Fauchier L, Goette A, Kalman J, Kalra L, Kim YH, Lane DA, Lip GYH, Lubitz SA, Márquez MF, Potpara T, Pozzer DL, Ruskin JN, Savelieva I, Teo WS, Tse HF, Verma A, Zhang S, Chung M (2018). European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?. Heart rhythm, 15(6), e37-e60.
60. Vergara P, Tzou WS, Tung R, Brombin C, Nonis A, Vaseghi M, Frankel DS, Di Biase L, Tedrow U, Mathuria N, Nakahara S, Tholakanahalli V, Bunch TJ, Weiss JP, Dickfeld T, Lakireddy D, Burkhardt JD, Santangeli P, Callans D, Natale A, Marchlinski F, Stevenson WG, Shivkumar K, Sauer WH, Della Bella (2018). Predictive Score for Identifying Survival and Recurrence Risk Profiles in Patients Undergoing Ventricular Tachycardia Ablation. Circulation. Arrhythmia and electrophysiology, 11(12), e006730.
61. Mujovi¿ N, Marinkovi¿ M, Markovi¿ N, Vu'i¿evi¿ V, Lip GYH, Bunch TJ, Potpara T (2018). The relationship of early recurrence of atrial fibrillation and the 3-month integrity of the ablation lesion set. Scientific reports, 8(1), 9875.
62. Graves KG, May HT, Knowlton KU, Muhlestein JB, Jacobs V, Lappé DL, Anderson JL, Horne BD, Bunch T (2018). Improving CHA2DS2-VASc stratification of non-fatal stroke and mortality risk using the Intermountain Mortality Risk Score among patients with atrial fibrillation. Open heart, 5(2), e000907.
63. Dagres N, Chao TF, Fenelon G, Aguinaga L, Benhayon D, Benjamin EJ, Bunch TJ, Chen LY, Chen SA, Darrieux F, de Paola A, Fauchier L, Goette A, Kalman J, Kalra L, Kim YH, Lane DA, Lip GYH, Lubitz SA, Márquez MF, Potpara T, Pozzer DL, Ruskin JN, Savelieva I, Teo WS, Tse HF, Verma A, Zhang S, Chung MK, Bautista-Vargas WF, Chiang CE, Cuesta A, Dan GA, Frankel DS, Guo Y, Hatala R, Lee YS, Murakawa Y, Pellegrini CN, Pinho C, Milan DJ, Morin DP, Nadalin E, Ntaios G, Prabhu MA, Proietti M, Rivard L, Valentino M, Shantsila (2018). European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: What is the best practice?. Journal of arrhythmia, 34(2), 99-123.
64. Vaseghi M, Hu TY, Tung R, Vergara P, Frankel DS, Di Biase L, Tedrow UB, Gornbein JA, Yu R, Mathuria N, Nakahara S, Tzou WS, Sauer WH, Burkhardt JD, Tholakanahalli VN, Dickfeld TM, Weiss JP, Bunch TJ, Reddy M, Callans DJ, Lakkireddy DR, Natale A, Marchlinski FE, Stevenson WG, Della Bella P, Shivkumar (2018). Outcomes of Catheter Ablation of Ventricular Tachycardia Based on Etiology in Nonischemic Heart Disease: An International Ventricular Tachycardia Ablation Center Collaborative Study. JACC. Clinical electrophysiology, 4(9), 1141-1150.
65. Basu-Ray I, Sudhakar D, Schwing G, Monlezun D, Zhang L, Shah SK, Pujara D, Ting K, Rafeh NA, Ali G, Cassidy M, Ellenbogen K, Levine G, Lam W, Mathuria N, Saeed M, Bunch J, Martin-Schild S, Gold M, Aryana A, Razavi M, Rasekh (2018). Complex Left Atrial Appendage Morphology Is an Independent Risk Factor for Cryptogenic Ischemic Stroke. Frontiers in cardiovascular medicine, 5, 131.
66. Chatterjee NA, Moorthy MV, Pester J, Schaecter A, Panicker GK, Narula D, Lee DC, Goldberger JJ, Kadish A, Cook NR, Albert CM, PRE-DETERMINE Study Group (2018). Sudden Death in Patients With Coronary Heart Disease Without Severe Systolic Dysfunction. JAMA cardiology, 3(7), 591-600.
67. Horne BD, Muhlestein JB, Bennett ST, Muhlestein JB, Jensen KR, Marshall D, Bair TL, May HT, Carlquist JF, Hegewald M, Knight S, Le VT, Bunch TJ, Lappé DL, Anderson JL, Knowlton K (2018). Extreme erythrocyte macrocytic and microcytic percentages are highly predictive of morbidity and mortality. JCI insight, 3(14),
68. Golive A, May HT, Bair TL, Jacobs V, Crandall BG, Cutler MJ, Day JD, Mallender C, Osborn JS, Stevens SM, Weiss JP, Woller SC, Bunch T (2017). The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial Fibrillation. The American journal of cardiology, 120(1), 75-82.
69. Aryana A, d'Avila A, Cool CL, Miller MA, Garcia FC, Supple GE, Dukkipati SR, Lakkireddy D, Bunch TJ, Bowers MR, O'Neill PG, Reddy VY, Marchlinski F (2017). Outcomes of catheter ablation of ventricular tachycardia with mechanical hemodynamic support: An analysis of the Medicare database. Journal of cardiovascular electrophysiology, 28(11), 1295-1302.
70. Mason S, Osborn JS, Dhar R, Tonkin A, Ethington JD, Le V, Benuzillo J, Lappe DL, Knowlton KU, Bunch TJ, Anderson J (2017). Real world MRI experience with nonconditional and conditional cardiac rhythm devices after MagnaSafe. Journal of cardiovascular electrophysiology, 28(12), 1468-1474.
71. Mujovi¿ N, Marinkovi¿ M, Markovi¿ N, Stankovi¿ G, Lip GYH, Blomstrom-Lundqvist C, Bunch TJ, Potpara T (2017). Persistency of left atrial linear lesions after radiofrequency catheter ablation for atrial fibrillation: Data from an invasive follow-up electrophysiology study. Journal of cardiovascular electrophysiology, 28(12), 1403-1414.
72. Jacobs V, May HT, Bair TL, Crandall BG, Cutler DO MJ, Day JD, Mallender C, Osborn JS, Weiss JP, Bunch T (2017). Long-term aspirin does not lower risk of stroke and increases bleeding risk in low-risk atrial fibrillation ablation patients. Journal of cardiovascular electrophysiology, 28(11), 1241-1246.
73. Anselmino M, Matta M, Bunch TJ, Fiala M, Scaglione M, Nölker G, Qian P, Neumann T, Ferraris F, Gaita (2017). Conduction recovery following catheter ablation in patients with recurrent atrial fibrillation and heart failure. International journal of cardiology, 240, 240-245.
74. Santangeli P, Frankel DS, Tung R, Vaseghi M, Sauer WH, Tzou WS, Mathuria N, Nakahara S, Dickfeldt TM, Lakkireddy D, Bunch TJ, Di Biase L, Natale A, Tholakanahalli V, Tedrow UB, Kumar S, Stevenson WG, Della Bella P, Shivkumar K, Marchlinski FE, Callans DJ, International VT Ablation Center Collaborative Group (2017). Early Mortality After Catheter Ablation of Ventricular Tachycardia in Patients With Structural Heart Disease. Journal of the American College of Cardiology, 69(17), 2105-2115.
75. Afshar K, Bunch T (2017). Return-to-Play in 2017 and the Role of Shared Decision-Making in Patients with Inherited and Acquired Channelopathies and Cardiomyopathies. Current treatment options in cardiovascular medicine, 19(10), 75.
76. Jacobs V, Graves KG, Bunch T (2017). Anticoagulant use in atrial fibrillation and risk of dementia: review of contemporary knowledge. Expert review of cardiovascular therapy, 15(12), 897-903.
77. Tzou WS, Tung R, Frankel DS, Di Biase L, Santangeli P, Vaseghi M, Bunch TJ, Weiss JP, Tholakanahalli VN, Lakkireddy D, Vunnam R, Dickfeld T, Mathuria N, Tedrow U, Vergara P, Vakil K, Nakahara S, Burkhardt JD, Stevenson WG, Callans DJ, Della Bella P, Natale A, Shivkumar K, Marchlinski FE, Sauer W (2017). Outcomes after repeat ablation of ventricular tachycardia in structural heart disease: An analysis from the International VT Ablation Center Collaborative Group. Heart rhythm, 14(7), 991-997.
78. Tzou WS, Tung R, Frankel DS, Vaseghi M, Bunch TJ, Di Biase L, Tholakanahalli VN, Lakkireddy D, Dickfeld T, Saliaris A, Weiss JP, Mathuria N, Tedrow U, Afzal MR, Vergara P, Nagashima K, Patel M, Nakahara S, Vakil K, Burkhardt JD, Tseng CH, Natale A, Shivkumar K, Callans DJ, Stevenson WG, Della Bella P, Marchlinski FE, Sauer W (2017). Ventricular Tachycardia Ablation in Severe Heart Failure: An International Ventricular Tachycardia Ablation Center Collaboration Analysis. Circulation. Arrhythmia and electrophysiology, 10(1),
79. Vakil K, Garcia S, Tung R, Vaseghi M, Tedrow U, Della Bella P, Frankel DS, Vergara P, Di Biase L, Nagashima K, Nakahara S, Tzou WS, Burkhardt JD, Dickfeld T, Weiss JP, Bunch J, Callans D, Lakkireddy D, Natale A, Sauer WH, Stevenson WG, Marchlinski F, Shivkumar K, Tholakanahalli V (2017). Ventricular Tachycardia Ablation in the Elderly: An International Ventricular Tachycardia Center Collaborative Group Analysis. Circulation. Arrhythmia and electrophysiology, 10(12),
80. Turagam MK, Vuddanda V, Atkins D, Santangeli P, Frankel DS, Tung R, Vaseghi M, Sauer WH, Tzou W, Mathuria N, Nakahara S, Dickfeld TM, Bunch TJ, Weiss P, Di Biase L, Tholakanahalli V, Vakil K, Tedrow UB, Stevenson WG, Della Bella P, Shivkumar K, Marchlinski FE, Callans DJ, Natale A, Reddy M, Lakkireddy (2017). Hemodynamic Support in Ventricular Tachycardia Ablation: An International VT Ablation Center Collaborative Group Study. JACC. Clinical electrophysiology, 3(13), 1534-1543.
81. Jacobs V, May HT, Bair TL, Crandall BG, Cutler MJ, Day JD, Mallender C, Osborn JS, Stevens SM, Weiss JP, Woller SC, Bunch T (2016). Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation. The American journal of cardiology, 118(2), 210-4.
82. Bunch TJ, May HT, Bair TL, Jacobs V, Crandall BG, Cutler M, Weiss JP, Mallender C, Osborn JS, Anderson JL, Day J (2016). The Impact of Age on 5-Year Outcomes After Atrial Fibrillation Catheter Ablation. Journal of cardiovascular electrophysiology, 27(2), 141-6.
83. Weiss JP, May HT, Bair TL, Crandall BG, Cutler MJ, Day JD, Osborn JS, Mallender C, Bunch T (2016). A Comparison of Remote Magnetic Irrigated Tip Ablation versus Manual Catheter Irrigated Tip Catheter Ablation With and Without Force Sensing Feedback. Journal of cardiovascular electrophysiology, 27 Suppl 1, S5-S10.
84. Bunch TJ, May HT, Bair TL, Crandall BG, Cutler MJ, Jacobs V, Mallender C, Muhlestein JB, Osborn JS, Weiss JP, Day J (2016). Long-term influence of body mass index on cardiovascular events after atrial fibrillation ablation. Journal of interventional cardiac electrophysiology, 46(3), 259-65.
85. Lappe JM, Cutler MJ, Day JD, Bunch T (2016). Ablation for Persistent Atrial Fibrillation-Is There a Role for More Than PVI?. Current treatment options in cardiovascular medicine, 18(3), 15.
86. Carlquist JF, Knight S, Cawthon RM, Le VT, Jared Bunch T, Horne BD, Rollo JS, Huntinghouse JA, Brent Muhlestein J, Anderson J (2016). Shortened telomere length is associated with paroxysmal atrial fibrillation among cardiovascular patients enrolled in the Intermountain Heart Collaborative Study. Heart rhythm, 13(1), 21-7.
87. Knight S, McCubrey RO, Yuan Z, Woller SC, Horne BD, Bunch TJ, Le VT, Mills RM, Muhlestein J (2016). Adverse cardiovascular events in acute coronary syndrome with indications for anticoagulation. Therapeutic advances in cardiovascular disease, 10(4), 231-41.
88. Bunch TJ, May HT, Bair TL, Crandall BG, Cutler MJ, Day JD, Jacobs V, Mallender C, Osborn JS, Stevens SM, Weiss JP, Woller S (2016). Atrial Fibrillation Patients Treated With Long-Term Warfarin Anticoagulation Have Higher Rates of All Dementia Types Compared With Patients Receiving Long-Term Warfarin for Other Indications. Journal of the American Heart Association, 5(7),
89. Frankel DS, Tung R, Santangeli P, Tzou WS, Vaseghi M, Di Biase L, Nagashima K, Tedrow U, Bunch TJ, Tholakanahalli VN, Dendi R, Reddy M, Lakkireddy D, Dickfeld T, Weiss JP, Mathuria N, Vergara P, Patel M, Nakahara S, Vakil K, Sauer WH, Callans DJ, Natale A, Stevenson WG, Della Bella P, Shivkumar K, Marchlinski F (2016). Sex and Catheter Ablation for Ventricular Tachycardia: An International Ventricular Tachycardia Ablation Center Collaborative Group Study. JAMA cardiology, 1(8), 938-944.
90. Bunch (2016). MY APPROACH to a patient with atrial fibrillation and dementia. Trends in cardiovascular medicine, 26(3), 293-4.
91. Kanmanthareddy A, Vallakati A, Reddy Yeruva M, Dixit S, DI Biase L, Mansour M, Boolani H, Gunda S, Bunch TJ, Day JD, Ruskin JN, Buddam A, Koripalli S, Bommana S, Natale A, Lakkireddy (2015). Pulmonary vein isolation for atrial fibrillation in the postpneumonectomy population: a feasibility, safety, and outcomes study. Journal of cardiovascular electrophysiology, 26(4), 385-389.
92. Bunch TJ, May HT, Bair TL, Jacobs V, Crandall BG, Cutler M, Weiss JP, Mallender C, Osborn JS, Anderson JL, Day J (2015). Five-year outcomes of catheter ablation in patients with atrial fibrillation and left ventricular systolic dysfunction. Journal of cardiovascular electrophysiology, 26(4), 363-370.
93. Jacobs V, Woller SC, Stevens SM, May HT, Bair TL, Crandall BG, Cutler M, Day JD, Weiss JP, Osborn JS, Mallender C, Anderson JL, Bunch T (2015). Percent Time With a Supratherapeutic INR in Atrial Fibrillation Patients Also Using an Antiplatelet Agent Is Associated With Long-Term Risk of Dementia. Journal of cardiovascular electrophysiology, 26(11), 1180-1186.
94. Calkins H, Awtry EH, Bunch TJ, Kaul S, Miller JM, Tedrow U (2015). COCATS 4 Task Force 11: Training in Arrhythmia Diagnosis and Management, Cardiac Pacing, and Electrophysiology. Journal of the American College of Cardiology, 65(17), 1854-65.
95. Reddy VY, Exner DV, Cantillon DJ, Doshi R, Bunch TJ, Tomassoni GF, Friedman PA, Estes NA 3rd, Ip J, Niazi I, Plunkitt K, Banker R, Porterfield J, Ip JE, Dukkipati SR, LEADLESS II Study Investigators (2015). Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker. The New England journal of medicine, 373(12), 1125-35.
96. Rollo J, Knight S, May HT, Anderson JL, Muhlestein JB, Bunch TJ, Carlquist (2015). Incidence of dementia in relation to genetic variants at PITX2, ZFHX3, and ApoE ¿4 in atrial fibrillation patients. Pacing and clinical electrophysiology, 38(2), 171-7.
97. Jacobs V, Cutler MJ, Day JD, Bunch T (2015). Atrial fibrillation and dementia. Trends in cardiovascular medicine, 25(1), 44-51.
98. Anselmino M, Matta M, D'ascenzo F, Pappone C, Santinelli V, Bunch TJ, Neumann T, Schilling RJ, Hunter RJ, Noelker G, Fiala M, Frontera A, Thomas G, Katritsis D, Jais P, Weerasooriya R, Kalman JM, Gaita (2015). Catheter ablation of atrial fibrillation in patients with diabetes mellitus: a systematic review and meta-analysis. Europace, 17(10), 1518-25.
99. Sheldon SH, Bunch TJ, Cogert GA, Acker NG, Dalzell CM, Higgins JV, Espinosa RE, Asirvatham SJ, Cha YM, Felmlee JP, Watson RE Jr, Anderson JL, Brooks MH, Osborn JS, Friedman P (2015). Multicenter study of the safety and effects of magnetic resonance imaging in patients with coronary sinus left ventricular pacing leads. Heart rhythm, 12(2), 345-9.
100. Jacobs V, May HT, Bair TL, Crandall BG, Cutler M, Day JD, Weiss JP, Osborn JS, Muhlestein JB, Anderson JL, Mallender C, Bunch T (2015). The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation. Heart rhythm, 12(4), 681-6.
101. Tung R, Vaseghi M, Frankel DS, Vergara P, Di Biase L, Nagashima K, Yu R, Vangala S, Tseng CH, Choi EK, Khurshid S, Patel M, Mathuria N, Nakahara S, Tzou WS, Sauer WH, Vakil K, Tedrow U, Burkhardt JD, Tholakanahalli VN, Saliaris A, Dickfeld T, Weiss JP, Bunch TJ, Reddy M, Kanmanthareddy A, Callans DJ, Lakkireddy D, Natale A, Marchlinski F, Stevenson WG, Della Bella P, Shivkumar (2015). Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study. Heart rhythm, 12(9), 1997-2007.
102. Bunch TJ, May HT, Bair TL, Anderson JL, Crandall BG, Cutler MJ, Jacobs V, Mallender C, Muhlestein JB, Osborn JS, Weiss JP, Day J (2015). Long-Term Natural History of Adult Wolff-Parkinson-White Syndrome Patients Treated With and Without Catheter Ablation. Circulation. Arrhythmia and electrophysiology, 8(6), 1465-71.
103. Reiffel JA, Camm AJ, Belardinelli L, Zeng D, Karwatowska-Prokopczuk E, Olmsted A, Zareba W, Rosero S, Kowey P, HARMONY Investigators (2015). The HARMONY Trial: Combined Ranolazine and Dronedarone in the Management of Paroxysmal Atrial Fibrillation: Mechanistic and Therapeutic Synergism. Circulation. Arrhythmia and electrophysiology, 8(5), 1048-56.
104. Knight S, Klaskala W, Woller SC, Horne BD, Bunch TJ, Le VT, Mills RM, Muhlestein J (2015). Antithrombotic therapy in patients with acute coronary syndrome in the intermountain heart collaborative study. Cardiology research and practice, 2015, 270508.
105. Bunch TJ, Cutler M (2015). Is pulmonary vein isolation still the cornerstone in atrial fibrillation ablation?. Journal of thoracic disease, 7(2), 132-41.
106. Whisenant B, Kar S, Bunch T (2014). Left atrial appendage occlusion addresses the tremendous unmet needs of stroke prevention in atrial fibrillation that persist despite recent advances in anticoagulation therapy. Circulation, 130(17), 1516-23.
107. Tong CW, Ahmad T, Brittain EL, Bunch TJ, Damp JB, Dardas T, Hijar A, Hill JA, Hilliard AA, Houser SR, Jahangir E, Kates AM, Kim D, Lindman BR, Ryan JJ, Rzeszut AK, Sivaram CA, Valente AM, Freeman A (2014). Challenges facing early career academic cardiologists. Journal of the American College of Cardiology, 63(21), 2199-208.
108. Brunner KJ, Bunch TJ, Mullin CM, May HT, Bair TL, Elliot DW, Anderson JL, Mahapatra (2014). Clinical predictors of risk for atrial fibrillation: implications for diagnosis and monitoring. Mayo Clinic proceedings, 89(11), 1498-505.
109. Bunch TJ, Anderson J (2014). Adjuvant antiarrhythmic therapy in patients with implantable cardioverter defibrillators. American journal of cardiovascular drugs, 14(2), 89-100.
110. Bunch TJ, Weiss JP, Crandall BG, Day JD, May HT, Bair TL, Osborn JS, Mallender C, Fischer A, Brunner KJ, Mahapatra (2014). Patients treated with catheter ablation for ventricular tachycardia after an ICD shock have lower long-term rates of death and heart failure hospitalization than do patients treated with medical management only. Heart rhythm, 11(4), 533-40.
111. Jacobs V, Woller SC, Stevens S, May HT, Bair TL, Anderson JL, Crandall BG, Day JD, Johanning K, Long Y, Mallender C, Olson JL, Osborn JS, Weiss JP, Bunch T (2014). Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementia. Heart rhythm, 11(12), 2206-13.
112. Reddy YM, Chinitz L, Mansour M, Bunch TJ, Mahapatra S, Swarup V, Di Biase L, Bommana S, Atkins D, Tung R, Shivkumar K, Burkhardt JD, Ruskin J, Natale A, Lakkireddy (2014). Percutaneous left ventricular assist devices in ventricular tachycardia ablation: multicenter experience. Circulation. Arrhythmia and electrophysiology, 7(2), 244-50.
113. Anselmino M, Matta M, D'Ascenzo F, Bunch TJ, Schilling RJ, Hunter RJ, Pappone C, Neumann T, Noelker G, Fiala M, Bertaglia E, Frontera A, Duncan E, Nalliah C, Jais P, Weerasooriya R, Kalman JM, Gaita (2014). Catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis. Circulation. Arrhythmia and electrophysiology, 7(6), 1011-8.
114. Labedi MR, Alharethi R, Kfoury AG, Budge D, Bruce R, Rasmusson B, Bunch T (2013). Electromagnetic interference of automatic implantable cardioverter defibrillator and HeartWare left ventricular assist device. ASAIO journal (American Society for Artificial Internal Organs, 59(2), 136-9.
115. Bunch TJ, May HT, Crandall BG, Weiss JP, Bair TL, Osborn JS, Anderson JL, Muhlestein JB, Lappe DL, Johnson DL, Day J (2013). Intracardiac ultrasound for esophageal anatomic assessment and localization during left atrial ablation for atrial fibrillation. Journal of cardiovascular electrophysiology, 24(1), 33-9.
116. Bunch T (2013). Elderly in-hospital cardiac arrest patients who are resuscitated with neurological recovery experience favourable long-term survival similar to non-arrest heart failure patients. Evidence-based medicine, 18(6), 227-8.
117. Bunch TJ, May HT, Bair TL, Weiss JP, Crandall BG, Osborn JS, Mallender C, Anderson JL, Muhlestein BJ, Lappe DL, Day J (2013). Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score. Heart rhythm, 10(9), 1272-7.
118. Bunch TJ, May HT, Bair TL, Johnson DL, Weiss JP, Crandall BG, Osborn JS, Anderson JL, Muhlestein JB, Lappe DL, Day J (2013). Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long-term outcomes. Heart rhythm, 10(9), 1257-62.
119. Horne BD, Lappé DL, Muhlestein JB, May HT, Ronnow BS, Brunisholz KD, Kfoury AG, Bunch TJ, Alharethi R, Budge D, Whisenant BK, Bair TL, Jensen KR, Anderson J (2013). Repeated measurement of the intermountain risk score enhances prognostication for mortality. PloS one, 8(7), e69160.
120. Roy RR, Sagar S, Bunch TJ, Aman W, Crusan DJ, Srivathsan K, Asirvatham SJ, Shen WK, Jahangir (2013). Hiatal Hernia Is Associated With an Increased Prevalence of Atrial Fibrillation in Young Patients. Journal of atrial fibrillation, 6(2), 894.
121. Johnson DL, Day JD, Doty JR, Bunch T (2012). Atrial fibrillation and atrial flutter: nonpharmacologic therapy. Clinics in geriatric medicine, 28(4), 649-63.
122. Bunch TJ, Darby A, May HT, Ragosta M, Lim DS, Taylor AM, DiMarco JP, Ailawadi G, Revenaugh JR, Weiss JP, Mahapatra (2012). Efficacy and safety of ventricular tachycardia ablation with mechanical circulatory support compared with substrate-based ablation techniques. Europace, 14(5), 709-14.
123. Brann A, Day JD, Bunch T (2012). The Role of Anticoagulation in a Patient with Atrial Fibrillation and a CHADS2 Score of 1. Cardiac electrophysiology clinics, 4(2), 107-17.
124. Bunch TJ, Crandall BG, Weiss JP, May HT, Bair TL, Osborn JS, Anderson JL, Muhlestein JB, Horne BD, Lappe DL, Day J (2011). Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation. Journal of cardiovascular electrophysiology, 22(8), 839-45.
125. Malasana G, Day JD, Weiss JP, Crandall BG, Bair TL, May HT, Osborn JS, Anderson JL, Muhlestein JB, Lappe DL, Nelson J, Bunch T (2011). A strategy of rapid cardioversion minimizes the significance of early recurrent atrial tachyarrhythmias after ablation for atrial fibrillation. Journal of cardiovascular electrophysiology, 22(7), 761-6.
126. Bunch TJ, Gersh B (2011). Rhythm control strategies and the role of antiarrhythmic drugs in the management of atrial fibrillation: focus on clinical outcomes. Journal of general internal medicine, 26(5), 531-7.
127. Bunch TJ, Horne BD, Asirvatham SJ, Day JD, Crandall BG, Weiss JP, Osborn JS, Anderson JL, Muhlestein JB, Lappe DL, Pope CA 3r (2011). Atrial fibrillation hospitalization is not increased with short-term elevations in exposure to fine particulate air pollution. Pacing and clinical electrophysiology, 34(11), 1475-9.
128. Bunch TJ, Mahapatra S, Murdock D, Molden J, Weiss JP, May HT, Bair TL, Mader KM, Crandall BG, Day JD, Osborn JS, Muhlestein JB, Lappe DL, Anderson J (2011). Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks. Pacing and clinical electrophysiology, 34(12), 1600-6.
129. Mahapatra S, LaPar DJ, Bhamidipati CM, McDaniel G, Kamath S, Bunch TJ, Ailawadi (2011). Incidence, risk factors, and consequences of new-onset atrial fibrillation following epicardial ablation for ventricular tachycardia. Europace, 13(4), 548-54.
130. Bunch TJ, May HT, Bair TL, Crandall BG, Weiss JP, Osborn JS, Anderson JL, Muhlestein JB, Horne BD, Lappe DL, Day J (2011). Trends in early and late mortality in patients undergoing coronary catheterization for myocardial infarction: implications on observation periods and risk factors to determine ICD candidacy. Heart rhythm, 8(9), 1460-6.
131. Horne BD, Muhlestein JB, Lappé DL, Brunisholz KD, May HT, Kfoury AG, Carlquist JF, Alharethi R, Budge D, Whisenant BK, Bunch TJ, Ronnow BS, Rasmusson KD, Bair TL, Jensen KR, Anderson J (2011). The intermountain risk score predicts incremental age-specific long-term survival and life expectancy. Translational research, 158(5), 307-14.
132. Bunch TJ, Weiss JP, Crandall BG, Day JD, DiMarco JP, Ferguson JD, Mason PK, McDaniel G, Osborn JS, Wiggins D, Mahapatra (2010). Image integration using intracardiac ultrasound and 3D reconstruction for scar mapping and ablation of ventricular tachycardia. Journal of cardiovascular electrophysiology, 21(6), 678-84.
133. Smith MB, Christensen N, Wang S, Strohecker J, Day JD, Weiss JP, Crandall BG, Osborn JS, Anderson JL, Horne BD, Muhlestein JB, Lappe DL, Moss H, Oliver J, Viau K, Bunch T (2010). Warfarin knowledge in patients with atrial fibrillation: implications for safety, efficacy, and education strategies. Cardiology, 116(1), 61-9.
134. Bunch TJ, Weiss JP, Crandall BG, May HT, Bair TL, Osborn JS, Anderson JL, Lappe DL, Muhlestein JB, Nelson J, Day J (2010). Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in octogenarians. Pacing and clinical electrophysiology, 33(2), 146-52.
135. Mirzoyev SA, McLeod CJ, Bunch TJ, Bell MR, White R (2010). Hypokalemia during the cooling phase of therapeutic hypothermia and its impact on arrhythmogenesis. Resuscitation, 81(12), 1632-6.
136. Halámek J, Jurák P, Bunch TJ, Lipoldová J, Novák M, Vondra V, Leinveber P, Plachy M, Kara T, Villa M, Frána P, Soucek M, Somers VK, Asirvatham S (2010). Use of a novel transfer function to reduce repolarization interval hysteresis. Journal of interventional cardiac electrophysiology, 29(1), 23-32.
137. Horne BD, May HT, Kfoury AG, Renlund DG, Muhlestein JB, Lappé DL, Rasmusson KD, Bunch TJ, Carlquist JF, Bair TL, Jensen KR, Ronnow BS, Anderson J (2010). The Intermountain Risk Score (including the red cell distribution width) predicts heart failure and other morbidity endpoints. European journal of heart failure, 12(11), 1203-13.
138. Mahapatra S, Tucker-Schwartz J, Wiggins D, Gillies GT, Mason PK, McDaniel G, Lapar DJ, Stemland C, Sosa E, Ferguson JD, Bunch TJ, Ailawadi G, Scanavacca (2010). Pressure frequency characteristics of the pericardial space and thorax during subxiphoid access for epicardial ventricular tachycardia ablation. Heart rhythm, 7(5), 604-9.
139. Bunch TJ, Weiss JP, Crandall BG, May HT, Bair TL, Osborn JS, Anderson JL, Muhlestein JB, Horne BD, Lappe DL, Day J (2010). Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia. Heart rhythm, 7(4), 433-7.
140. Bunch TJ, Anderson JL, May HT, Muhlestein JB, Horne BD, Crandall BG, Weiss JP, Lappé DL, Osborn JS, Day J (2009). Relation of bisphosphonate therapies and risk of developing atrial fibrillation. The American journal of cardiology, 103(6), 824-8.
141. Bunch TJ, Day JD, Packer D (2009). Insights into energy delivery to myocardial tissue during radiofrequency ablation through application of the first law of thermodynamics. Journal of cardiovascular electrophysiology, 20(4), 461-5.
142. Bunch TJ, Crandall BG, Weiss JP, May HT, Bair TL, Osborn JS, Anderson JL, Lappe DL, Muhlestein JB, Nelson J, Allison S, Foley T, Anderson L, Day J (2009). Warfarin is not needed in low-risk patients following atrial fibrillation ablation procedures. Journal of cardiovascular electrophysiology, 20(9), 988-93.
143. Okumura Y, Henz BD, Bunch TJ, Dalegrave C, Johnson SB, Packer D (2009). Distortion of right superior pulmonary vein anatomy by balloon catheters as a contributor to phrenic nerve injury. Journal of cardiovascular electrophysiology, 20(10), 1151-7.
144. Ahmadi-Kashani M, Kessler DJ, Day J, Bunch TJ, Stolen KQ, Brown S, Sbaity S, Olshansky B, INTRINSIC RV Study Investigators (2009). Heart rate predicts outcomes in an implantable cardioverter-defibrillator population. Circulation, 120(21), 2040-5.
145. Crandall MA, Horne BD, Day JD, Anderson JL, Muhlestein JB, Crandall BG, Weiss JP, Osborne JS, Lappé DL, Bunch T (2009). Atrial fibrillation significantly increases total mortality and stroke risk beyond that conveyed by the CHADS2 risk factors. Pacing and clinical electrophysiology, 32(8), 981-6.
146. Crandall MA, Horne BD, Day JD, Anderson JL, Muhlestein JB, Crandall BG, Weiss JP, Lappé DL, Bunch T (2009). Atrial fibrillation and CHADS2 risk factors are associated with highly sensitive C-reactive protein incrementally and independently. Pacing and clinical electrophysiology, 32(5), 648-52.
147. Bunch TJ, Day JD, Olshansky B, Stolen KQ, Mullin CM, INTRINSIC RV Study Investigators (2009). Newly detected atrial fibrillation in patients with an implantable cardioverter-defibrillator is a strong risk marker of increased mortality. Heart rhythm, 6(1), 2-8.
148. Malasana G, Day JD, Bunch T (2009). Atrial Fibrillation in Hypertrophic Obstructive Cardiomyopathy - Antiarrhythmics, Ablation and More!. Journal of atrial fibrillation, 2(3), 210.
149. Bunch TJ, Day JD, Anderson JL, Horne BD, Muhlestein JB, Crandall BG, Weiss JP, Lappe DL, Asirvatham S (2008). Frequency of helicobacter pylori seropositivity and C-reactive protein increase in atrial fibrillation in patients undergoing coronary angiography. The American journal of cardiology, 101(6), 848-51.
150. Ahmari SA, Bunch TJ, Modesto K, Stussy V, Dichak A, Seward JB, Pellikka PA, Chandrasekaran (2008). Impact of individual and cumulative coronary risk factors on coronary flow reserve assessed by dobutamine stress echocardiography. The American journal of cardiology, 101(12), 1694-9.
151. Bunch TJ, Packer DL, Jahangir A, Locke GR, Talley NJ, Gersh BJ, Roy RR, Hodge DO, Asirvatham S (2008). Long-term risk of atrial fibrillation with symptomatic gastroesophageal reflux disease and esophagitis. The American journal of cardiology, 102(9), 1207-11.
152. Bunch TJ, Rihal CS, Gumina RJ, Cooper L, Caplice N (2008). Progression of nonculprit plaque stenosis following successful percutaneous intervention. Angiology, 59(2), 236-9.
153. Bunch TJ, Munger TM, Friedman PA, Asirvatham SJ, Brady PA, Cha YM, Rea RF, Shen WK, Powell BD, Ommen SR, Monahan KH, Haroldson JM, Packer D (2008). Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy. Journal of cardiovascular electrophysiology, 19(10), 1009-14.
154. Okumura Y, Kolasa MW, Johnson SB, Bunch TJ, Henz BD, O'Brien CJ, Miller DV, Packer D (2008). Mechanism of tissue heating during high intensity focused ultrasound pulmonary vein isolation: implications for atrial fibrillation ablation efficacy and phrenic nerve protection. Journal of cardiovascular electrophysiology, 19(9), 945-51.
155. Okumura Y, Johnson SB, Bunch TJ, Henz BD, O'Brien CJ, Packer D (2008). A systematical analysis of in vivo contact forces on virtual catheter tip/tissue surface contact during cardiac mapping and intervention. Journal of cardiovascular electrophysiology, 19(6), 632-40.
156. Melduni RM, Oh JK, Bunch TJ, Sinak LJ, Gloviczki (2008). Reconstruction of occluded thoracic duct for treatment of chylopericardium: a novel surgical therapy. Journal of vascular surgery, 48(6), 1600-2.
157. Bunch TJ, White RD, Lopez-Jimenez F, Thomas R (2008). Association of body weight with total mortality and with ICD shocks among survivors of ventricular fibrillation in out-of-hospital cardiac arrest. Resuscitation, 77(3), 351-5.
158. Bunch TJ, Day J (2008). Novel ablative approach for atrial fibrillation to decrease risk of esophageal injury. Heart rhythm, 5(4), 624-7.
159. Bunch TJ, Ellenbogen KA, Packer DL, Asirvatham S (2008). Vagus nerve injury after posterior atrial radiofrequency ablation. Heart rhythm, 5(9), 1327-30.
160. Srivathsan KS, Bunch TJ, Asirvatham SJ, Edwards WD, Friedman PA, Munger TM, Hammill SC, Cha YM, Brady PA, Jahangir A, Bradley DJ, Rea RF, Packer DL, Shen W (2008). Mechanisms and utility of discrete great arterial potentials in the ablation of outflow tract ventricular arrhythmias. Circulation. Arrhythmia and electrophysiology, 1(1), 30-8.
161. Okumura Y, Henz BD, Johnson SB, Bunch TJ, O'Brien CJ, Hodge DO, Altman A, Govari A, Packer D (2008). Three-dimensional ultrasound for image-guided mapping and intervention: methods, quantitative validation, and clinical feasibility of a novel multimodality image mapping system. Circulation. Arrhythmia and electrophysiology, 1(2), 110-9.
162. Bunch TJ, Chandrasekaran K, Ehrsam JE, Hammill SC, Urban LH, Hodge DO, Ommen SR, Pellikka P (2007). Prognostic significance of exercise induced arrhythmias and echocardiographic variables in hypertrophic cardiomyopathy. The American journal of cardiology, 99(6), 835-8.
163. Bunch TJ, Hohnloser SH, Gersh B (2007). Mechanisms of sudden cardiac death in myocardial infarction survivors: insights from the randomized trials of implantable cardioverter-defibrillators. Circulation, 115(18), 2451-7.
164. Elesber AA, Lerman A, Denktas AE, Resch ZT, Jared Bunch T, Schwartz RS, Conover C (2007). Pregnancy associated plasma protein-A and risk stratification of patients presenting with chest pain in the emergency department. International journal of cardiology, 117(3), 365-9.
165. Bunch TJ, Connolly HM, Asirvatham SJ, Brady PA, Gersh BJ, Munger TM, Shen WK, Monahan KH, Packer D (2007). Catheter ablation for atrial fibrillation in patients with the Marfan and Marfan-like syndromes. Journal of interventional cardiac electrophysiology, 20(1-2), 15-20.
166. Bunch TJ, Kottke TE, Lopez-Jimenez F, Mahapatra S, Elesber AA, White R (2006). A comparative analysis of short- and long-term outcomes after ventricular fibrillation out-of-hospital cardiac arrest in patients with ischemic and nonischemic heart disease. The American journal of cardiology, 98(7), 857-60.
167. Ahmari SA, Bunch TJ, Chandra A, Chandra V, Ujino K, Daly RC, Kushwaha SS, Edwards BS, Maalouf YF, Seward JB, McGregor CG, Chandrasekaran (2006). Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter. The Journal of heart and lung transplantation, 25(1), 53-60.
168. Bunch TJ, Nelson J, Foley T, Allison S, Crandall BG, Osborn JS, Weiss JP, Anderson JL, Nielsen P, Anderson L, Lappe DL, Day J (2006). Temporary esophageal stenting allows healing of esophageal perforations following atrial fibrillation ablation procedures. Journal of cardiovascular electrophysiology, 17(4), 435-9.
169. Bunch TJ, Mahapatra S, Bruce GK, Johnson SB, Miller DV, Horne BD, Wang XL, Lee HC, Caplice NM, Packer D (2006). Impact of transforming growth factor-beta1 on atrioventricular node conduction modification by injected autologous fibroblasts in the canine heart. Circulation, 113(21), 2485-94.
170. Ahmari SA, Modesto K, Bunch J, Stussy V, Dichak A, Seward J, Pellikka P, Chandrasekaran (2006). Doppler derived coronary flow reserve during dobutamine stress echocardiography further improves detection of myocardial ischemia. European journal of echocardiography, 7(2), 134-40.
171. Muhlestein JB, Anderson JL, Cui C, Lan Y, Bair TL, Bunch TJ, Pearson RR, Sorensen SG, Renlund DG, Zhang L, Horne BD, Vincent GM (2005). Improved long-term survival associated with stent deployment during percutaneous coronary interventions: results from a registry of 3399 patients. Am Heart J, 150(1), 182-7.
172. Bunch TJ, Muhlestein JB, Bair TL, Renlund DG, Lappé DL, Jensen KR, Horne BD, Carter MA, Anderson JL, Intermountain Heart Collaborative Study Group (2005). Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure. The American journal of cardiology, 95(7), 827-31.
173. Jones HU, Muhlestein JB, Jones KW, Renlund DG, Bair TL, Bunch TJ, Horne BD, Lappé DL, Anderson JL, Doty D (2005). Early postoperative use of unfractionated heparin or enoxaparin is associated with increased surgical re-exploration for bleeding. The Annals of thoracic surgery, 80(2), 518-22.
174. Bunch TJ, Asirvatham SJ, Friedman PA, Monahan KH, Munger TM, Rea RF, Sinak LJ, Packer D (2005). Outcomes after cardiac perforation during radiofrequency ablation of the atrium. Journal of cardiovascular electrophysiology, 16(11), 1172-9.
175. Bunch TJ, Bruce GK, Mahapatra S, Johnson SB, Miller DV, Sarabanda AV, Milton MA, Packer D (2005). Mechanisms of phrenic nerve injury during radiofrequency ablation at the pulmonary vein orifice. Journal of cardiovascular electrophysiology, 16(12), 1318-25.
176. Bruce GK, Bunch TJ, Milton MA, Sarabanda A, Johnson SB, Packer D (2005). Discrepancies between catheter tip and tissue temperature in cooled-tip ablation: relevance to guiding left atrial ablation. Circulation, 112(7), 954-60.
177. Sarabanda AV, Bunch TJ, Johnson SB, Mahapatra S, Milton MA, Leite LR, Bruce GK, Packer D (2005). Efficacy and safety of circumferential pulmonary vein isolation using a novel cryothermal balloon ablation system. Journal of the American College of Cardiology, 46(10), 1902-12.
178. Bunch TJ, Hammill SC, White R (2005). Outcomes after ventricular fibrillation out-of-hospital cardiac arrest: expanding the chain of survival. Mayo Clinic proceedings, 80(6), 774-82.
179. Mahapatra S, Bunch TJ, White RD, Hodge DO, Packer D (2005). Sex differences in outcome after ventricular fibrillation in out-of-hospital cardiac arrest. Resuscitation, 65(2), 197-202.
180. White RD, Bunch TJ, Hankins D (2005). Evolution of a community-wide early defibrillation programme experience over 13 years using police/fire personnel and paramedics as responders. Resuscitation, 65(3), 279-83.
181. Bunch TJ, White R (2005). Trends in treated ventricular fibrillation in out-of-hospital cardiac arrest: ischemic compared to non-ischemic heart disease. Resuscitation, 67(1), 51-4.
182. Mahapatra S, Bybee KA, Bunch TJ, Espinosa RE, Sinak LJ, McGoon MD, Hayes D (2005). Incidence and predictors of cardiac perforation after permanent pacemaker placement. Heart rhythm, 2(9), 907-11.
183. Khan AH, Bunch TJ, White RD, Packer D (2004). Prognostic implication of early ejection fraction on long-term mortality and quality of life following out-of-hospital cardiac arrest. The American journal of cardiology, 93(8), 1027-30.
184. Muhlestein JB, Anderson JL, Horne BD, Carlquist JF, Bair TL, Bunch TJ, Pearson RR, Intermountain Heart Collaborative Study Group (2004). Early effects of statins in patients with coronary artery disease and high C-reactive protein. The American journal of cardiology, 94(9), 1107-12.
185. Horne BD, Muhlestein JB, Lappé DL, Renlund DG, Bair TL, Bunch TJ, Anderson JL, Intermountain Heart Collaborative Study Group (2004). Less affluent area of residence and lesser-insured status predict an increased risk of death or myocardial infarction after angiographic diagnosis of coronary disease. Annals of epidemiology, 14(2), 143-50.
186. Bunch TJ, West CP, Packer DL, Panutich MS, White R (2004). Admission predictors of in-hospital mortality and subsequent long-term outcome in survivors of ventricular fibrillation out-of-hospital cardiac arrest: a population-based study. Cardiology, 102(1), 41-7.
187. Bunch TJ, Bruce GK, Johnson SB, Sarabanda A, Milton MA, Packer D (2004). Analysis of catheter-tip (8-mm) and actual tissue temperatures achieved during radiofrequency ablation at the orifice of the pulmonary vein. Circulation, 110(19), 2988-95.
188. Bunch TJ, White RD, Khan AH, Packer D (2004). Impact of age on long-term survival and quality of life following out-of-hospital cardiac arrest. Critical care medicine, 32(4), 963-7.
189. Bunch TJ, Chandrasekaran K, Gersh BJ, Hammill SC, Hodge DO, Khan AH, Packer DL, Pellikka P (2004). The prognostic significance of exercise-induced atrial arrhythmias. Journal of the American College of Cardiology, 43(7), 1236-40.
190. Horton SC, Bunch T (2004). Patent foramen ovale and stroke. Mayo Clinic proceedings, 79(1), 79-88.
191. Bunch TJ, White RD, Gersh BJ, Shen WK, Hammill SC, Packer D (2004). Outcomes and in-hospital treatment of out-of-hospital cardiac arrest patients resuscitated from ventricular fibrillation by early defibrillation. Mayo Clinic proceedings, 79(5), 613-9.
192. Ghobrial IM, Bunch TJ, Caplice NM, Edwards WD, Miller DV, Litzow M (2004). Fatal coronary artery disease after unrelated donor bone marrow transplantation. Mayo Clinic proceedings, 79(3), 403-6.
193. Bunch TJ, White RD, Smith GE, Hodge DO, Gersh BJ, Hammill SC, Shen WK, Packer D (2004). Long-term subjective memory function in ventricular fibrillation out-of-hospital cardiac arrest survivors resuscitated by early defibrillation. Resuscitation, 60(2), 189-95.
194. Bunch TJ, White RD, Bruce GK, Hammill SC, Gersh BJ, Shen WK, Carter MA, Packer D (2004). Prediction of short- and long-term outcomes by electrocardiography in survivors of out-of-hospital cardiac arrest. Resuscitation, 63(2), 137-43.
195. Bunch TJ, White RD, Friedman PA, Kottke TE, Wu LA, Packer D (2004). Trends in treated ventricular fibrillation out-of-hospital cardiac arrest: a 17-year population-based study. Heart rhythm, 1(3), 255-9.
196. Jackson JD, Muhlestein JB, Bunch TJ, Bair TL, Horne BD, Madsen TE, Lappé JM, Anderson JL, Intermountain Heart Collaborative Study Group. (2003). Beta-blockers reduce the incidence of clinical restenosis: prospective study of 4840 patients undergoing percutaneous coronary revascularization. Am Heart J, 145(5), 875-81.
197. Keelan PC, Bunch TJ, White RD, Packer DL, Holmes DR J (2003). Early direct coronary angioplasty in survivors of out-of-hospital cardiac arrest. The American journal of cardiology, 91(12), 1461-3, A6.
198. Bunch TJ, Welsh GA, Miller DV, Santhi V (2003). Case report: acute spontaneous Achilles tendon rupture in a patient with giant cell arteritis. Annals of clinical and laboratory science, 33(3), 326-8.
199. Bunch TJ, Oh JK, Click R (2003). Subepicardial aneurysm of the left ventricle. Journal of the American Society of Echocardiography, 16(12), 1318-21.
200. Bunch TJ, White RD, Gersh BJ, Meverden RA, Hodge DO, Ballman KV, Hammill SC, Shen WK, Packer D (2003). Long-term outcomes of out-of-hospital cardiac arrest after successful early defibrillation. The New England journal of medicine, 348(26), 2626-33.
201. Caplice NM, Bunch TJ, Stalboerger PG, Wang S, Simper D, Miller DV, Russell SJ, Litzow MR, Edwards W (2003). Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proceedings of the National Academy of Sciences of the United States of America, 100(8), 4754-9.
202. Bunch TJ, Dunn WF, Basu A, Gosman RI (2002). Hyponatremia and hypoglycemia in acute Sheehan's syndrome. Gynecol Endocrinol, 16(5), 419-23.
203. Bunch TJ, Muhlestein JB, Anderson JL, Horne BD, Bair TL, Jackson JD, Li Q, Lappé D (2002). Effects of statins on six-month survival and clinical restenosis frequency after coronary stent deployment. The American journal of cardiology, 90(3), 299-302.
204. Bunch TJ, Thalji MK, Pellikka PA, Aksamit T (2002). Respiratory failure in tetanus: case report and review of a 25-year experience. Chest, 122(4), 1488-92.
205. Bunch TJ, Birskovich LM, Eiken P (2002). Diabetic myonecrosis in a previously healthy woman and review of a 25-year Mayo Clinic experience. Endocrine practice, 8(5), 343-6.
206. Bunch TJ, Abraham D, Wang S, Meikle A (2002). Pituitary radiographic abnormalities and clinical correlates of hypogonadism in elderly males presenting with erectile dysfunction. The aging male, 5(1), 38-46.
207. Muhlestein JB, Anderson JL, Carlquist JF, Salunkhe K, Horne BD, Pearson RR, Bunch TJ, Allen A, Trehan S, Nielson (2000). Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study. Circulation, 102(15), 1755-60.
208. Ferreira PJ, Bunch TJ, Albertine KH, Carlton D (2000). Circulating neutrophil concentration and respiratory distress in premature infants. The Journal of pediatrics, 136(4), 466-72.
209. Holyoak GR, Wang S, Liu G, Bunch TJ, Evans RC, Bunch T (1998). The effects of ceftiofur sodium (Naxcel) on bovine oocyte and preimplantation embryonic development assessed by in vitro embryo production techniques. Journal of veterinary pharmacology and therapeutics, 21(2), 92-8.
210. Wang S, Holyoak GR, Liu G, Bunch TJ, Evans RC, Bunch T (1998). Effects of resazurin on bovine oocyte fertilization and embryo development in vitro. Animal reproduction science, 51(3), 205-13.

Review

1. Nielsen JC, Lin YJ, de Oliveira Figueiredo MJ, Sepehri Shamloo A, Alfie A, Boveda S, Dagres N, Di Toro D, Eckhardt LL, Ellenbogen K, Hardy C, Ikeda T, Jaswal A, Kaufman E, Krahn A, Kusano K, Kutyifa V, S Lim H, Lip GYH, Nava-Townsend S, Pak HN, Rodríguez Diez G, Sauer W, Saxena A, Svendsen JH, Vanegas D, Vaseghi M, Wilde A, Bunch TJ, Buxton AE, Calvimontes G, Chao TF, Eckardt L, Estner H, Gillis AM, Isa R, Kautzner J, Maury P, Moss JD, Nam GB, Olshansky B, Molano LFP, Pimentel M, Prabhu M, Tzou WS, Sommer P, Swampillai J, Vidal A, Deneke T, Hindricks G, Leclercq (2020). European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population. Journal of arrhythmia, 36(4), 553-607.
2. Galenko O, Jacobs V, Bunch T (2020). Biomarkers in the risk assessment for stroke and dementia in atrial fibrillation. Current opinion in cardiology, 35(1), 1-7.
3. Volgman AS, Bairey Merz CN, Aggarwal NT, Bittner V, Bunch TJ, Gorelick PB, Maki P, Patel HN, Poppas A, Ruskin J, Russo AM, Waldstein SR, Wenger NK, Yaffe K, Pepine C (2019). Sex Differences in Cardiovascular Disease and Cognitive Impairment: Another Health Disparity for Women?. Journal of the American Heart Association, 8(19), e013154.
4. Johnson DL, Day JD, Mahapatra S, Bunch T (2012). Adverse Outcomes from Atrial Fibrillation;Mechanisms, Risks, and Insights Learned from Therapeutic Options. Journal of atrial fibrillation, 4(5), 477.
5. Packer DL, Johnson SB, Kolasa MW, Bunch TJ, Henz BD, Okumura (2008). New generation of electro-anatomic mapping: full intracardiac ultrasound image integration. Europace, 10 Suppl 3, iii35-41.

Conference Proceedings

1. Dagres N, Chao TF, Fenelon G, Aguinaga L, Benhayon D, Benjamin EJ, Bunch TJ, Chen LY, Chen SA, Darrieux F, de Paola A, Fauchier L, Goette A, Kalman J, Kalra L, Kim YH, Lane DA, Lip GYH, Lubitz SA, Márquez MF, Potpara T, Pozzer DL, Ruskin JN, Savelieva I, Teo WS, Tse HF, Verma A, Zhang S, Chung MK, ESC Scientific Document Group (2018). European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?. Europace, 20(9), 1399-1421.

Commentary

1. Bunch JT, Woller S (2019). Saving the brain from catheter ablation of atrial fibrillation: the role of pre- and peri-procedural anticoagulation. European heart journal, 40(19), 1538-1540.

Case Report

1. Melman YF, Steinberg BA, Lancaster J, Freedman RA, Bunch TJ, Cutler M (2021). Limitations of manufacturer-recommended remote monitoring in the St. Jude Assurity/Endurity battery recall. HeartRhythm case reports, 7(12), 791-794.
2. Wang L, Catino A, Sheppard T, U Shah R, Bunch TJ, A Steinberg (2020). Smartwatch Alert Mimicking Implantable Cardiac Defibrillator Alarm During Sleep. Journal of atrial fibrillation, 13(4), 2412.
3. Sandhu A, Borne RT, Mam C, Bunch TJ, Aleong R (2017). Double jeopardy: long QT3 and Brugada syndromes. Clinical case reports, 5(8), 1315-1319.

Editorial

1. Groh CA, Bunch T (2022). How to rebuild a damaged heart: The role of left bundle branch pacing to reduce functional mitral regurgitation. Heart rhythm,
2. Bunch T (2022). State of the Journal 2022: Heart Rhythm Case Reports. HeartRhythm case reports, 8(1), 1.
3. Kwaku KF, Bunch T (2022). Which Patients Benefit Most From Primary Prevention ICDs?: A Call for More Nuanced Risk Stratification. JACC. Clinical electrophysiology, 8(1), 12-14.
4. Bunch T (2021). Reflections from the Book of the Dead: Weighing the impact of epicardial fat on atrial fibrillation vulnerability. Journal of cardiovascular electrophysiology, 32(4), 900-902.
5. Groh CA, Bunch T (2021). Early recurrence of atrial tachyarrhythmia post-atrial fibrillation ablation: Filling in the blank. Heart rhythm, 18(9), 1471-1472.
6. Bunch T (2021). State of the Journal 2021: Heart Rhythm Case Reports. HeartRhythm case reports, 7(1), 1-2.
7. Bunch TJ, Steinberg B (2020). Revisiting Rate versus Rhythm Control in Atrial Fibrillation - Timing Matters. The New England journal of medicine, 383(14), 1383-1384.
8. Bunch T (2020). State of the Journal 2020: Heart Rhythm Case Reports. HeartRhythm case reports, 6(1), 1.
9. Bunch TJ, Ranjan (2020). Overestimation and Underweighting of Rare Events: The Challenge of Preventing Atrial-Esophageal Fistula After Ablation. JACC. Clinical electrophysiology, 6(3), 269-271.
10. Bunch T (2020). Electrophysiology Coup d'Oeil: The Art of Papillary Muscle PVC Ablation. JACC. Clinical electrophysiology, 6(11), 1393-1394.
11. Bunch T (2020). When it comes to the left atrial appendage, first do no harm. Heart rhythm, 17(2), 182-183.
12. Bunch T (2019). State of the Journal 2019: HeartRhythm Case Reports. HeartRhythm case reports, 5(1), 1.
13. Bunch T (2019). Who Will Benefit From an Implantable Cardioverter Defibrillator?. Circulation. Cardiovascular quality and outcomes, 12(8), e005995.
14. Bunch T (2018). Excessive contact force can overcome irrigated tip catheter benefits during atrial fibrillation ablation. Journal of cardiovascular electrophysiology, 29(2), 236-238.
15. Bunch T (2018). Let go to grow: Reconciling your dependence on fluoroscopy for atrial fibrillation ablations. Pacing and clinical electrophysiology, 41(11), 1412-1413.
16. Bunch T (2018). Mapping of atrial fibrillation: A test of faith. Heart rhythm, 15(6), 888-889.
17. Bunch T (2018). State of the Journal 2018: HeartRhythm Case Reports. HeartRhythm case reports, 4(1), 1.
18. Bunch TJ, Day J (2017). Is left atrial appendage isolation a pyrrhic victory in the effort to treat atrial fibrillation?. Journal of thoracic disease, 9(1), 1-4.
19. Jared Bunch (2017). State of the Journal 2017: HeartRhythm Case Reports. HeartRhythm case reports, 3(1), 1.
20. Bunch TJ, Cutler M (2016). How Carbon Beams May Make Extracorporeal Ablation for Atrial Fibrillation a Reality. Journal of cardiovascular electrophysiology, 27(3), 345-6.
21. Bunch TJ, May H (2016). Atrial fibrillation: a risk factor or risk marker?. European heart journal, 37(38), 2890-2892.
22. Bunch TJ, Jacobs (2016). Adverse brain aging in atrial fibrillation patients. Heart rhythm, 13(10), 2025-6.
23. Jared Bunch (2016). State of the journal 2016: HeartRhythm Case Reports. HeartRhythm case reports, 2(1), 1.
24. Bunch TJ, Day J (2015). Adverse Remodeling of the Left Atrium in Patients with Atrial Fibrillation: When Is the Tipping Point in Which Structural Changes Become Permanent?. Journal of cardiovascular electrophysiology, 26(6), 606-7.
25. Bunch TJ, Day J (2014). The electrophysiologist's new clothes and the cardiac MRI that told the truth. Journal of cardiovascular electrophysiology, 25(5), 464-465.
26. Bunch TJ, Day J (2013). The atrial fibrillation ablation theory of relativity. Journal of cardiovascular electrophysiology, 24(3), 267-8.
27. Bunch TJ, Mahapatra (2012). Implications of continuous QT monitoring in the intensive care setting. Critical care medicine, 40(2), 658-9.
28. Bunch TJ, Day J (2012). Phrenic nerve pacing during atrial ablation: a stimulus plan that works. Pacing and clinical electrophysiology, 35(9), 1050-2.
29. Bunch TJ, Day J (2012). Examining the risks and benefits of transesophageal echocardiogram imaging during catheter ablation for atrial fibrillation. Circulation. Arrhythmia and electrophysiology, 5(4), 621-3.
30. Bunch TJ, Day J (2011). Achieving favorable very long-term outcomes after catheter ablation for atrial fibrillation: an exciting adventure or delusional quest?. Journal of cardiovascular electrophysiology, 22(11), 1215-6.
31. Bunch TJ, Day J (2009). The significance of early atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a matter of time. Journal of cardiovascular electrophysiology, 20(12), 1326-7.
32. Bunch TJ, White R (2009). Education is what remains after medical emergency teams are trained. Critical care medicine, 37(12), 3174-5.
33. Hall N, Bunch T (2009). Defining new risk factors for out-of-hospital cardiac arrest: a hot opportunity for discovery. Critical care medicine, 37(12), 3178-9.
34. Bunch TJ, Day J (2009). Moving away from esophageal injury during left atrial ablation. Heart rhythm, 6(3), 323-4.
35. Bunch TJ, Day J (2008). The diagnostic evolution of the cardiac implantable electronic device: the implantable monitor of ischemia. Journal of cardiovascular electrophysiology, 19(3), 282-4.
36. Bunch TJ, White R (2008). A simplified approach to the challenging problem of resuscitation of patients who present in pulseless electrical activity. Critical care medicine, 36(2), 619-20.
37. Bunch TJ, Day J (2007). Unraveling the mysteries of catheter ablation for atrial fibrillation: from clinical observations to mechanistic explorations. Journal of cardiovascular electrophysiology, 18(3), 266-8.
38. Bunch TJ, White R (2007). Decision making with biomarkers after cardiac arrest: are we there yet?. Critical care medicine, 35(5), 1411-2.
39. Bunch TJ, Day J (2006). Right meets left: a common mechanism underlying right and left ventricular outflow tract tachycardias. Journal of cardiovascular electrophysiology, 17(10), 1059-61.
40. Bunch TJ, Ackerman M (2006). Promoting arrhythmia susceptibility. Circulation, 113(3), 330-2.

Letter

1. Nielsen JC, Lin YJ, de Oliviera Figueiredo MJ, Shamloo AS, Bunch T (2021). EHRA/HRS/APHRS/LAHRS expert consensus on risk assessment in cardiac arrhythmias: Authors' reply. Europace, 23(4), 649.
2. Reddy VY, Exner DV, Doshi R, Tomassoni G, Bunch TJ, Estes NAM, Neu'il P, Paulin FL, Garcia Guerrero JJ, Cantillon DJ, LEADLESS II Investigators (2021). Primary Results on Safety and Efficacy From the LEADLESS II-Phase 2 Worldwide Clinical Trial. JACC. Clinical electrophysiology, 8, 115-117.
3. Muhlestein JB, Muhlestein JB, Anderson JL, Bethea CF, Severance HW, Mentz RJ, Barsness GW, Barbagelata A, Albert D, Le VT, Bunch TJ, Yanowitz F, May HT, Chisum B, Ronnow BS, Duke University Cooperative Cardiovascular Society (DUCCS) investigators (2020). Smartphone 12-lead ECG-Exciting but must be handled with care. American heart journal, 226, 269.
4. Anselmino M, Matta M, D'Ascenzo F, Bunch TJ, Schilling RJ, Hunter RJ, Pappone C, Neumann T, Noelker G, Fiala M, Bertaglia E, Frontera A, Duncan E, Nalliah C, Jais P, Weerasooriya R, Kalman JM, Gaita (2015). Response to letter regarding "Catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis". Circulation. Arrhythmia and electrophysiology, 8(1), 246.

Other

1. Chew DS, Li Z, Steinberg BA, O'Brien EC, Pritchard J, Bunch TJ, Mark DB, Patel MR, Nabutovsky Y, Greiner MA, Piccini J (2022). Arrhythmic Burden and the Risk of Cardiovascular Outcomes in Patients With Paroxysmal Atrial Fibrillation and Cardiac Implanted Electronic Devices. Circulation. Arrhythmia and electrophysiology, 15(2), e010304.
2. Dar T, Turagam MK, Yarlagadda B, Parikh V, Pillarisetti J, Gopinathannair R, Gianni C, Mohanty S, Mansour M, Di Biase L, Bunch TJ, Natale A, Lakkireddy (2021). Outcomes of junctional ectopic tachycardia ablation in adult population-a multicenter experience. Journal of interventional cardiac electrophysiology, 61(1), 19-27.
3. Nielsen JC, Lin YJ, de Oliveira Figueiredo MJ, Sepehri Shamloo A, Alfie A, Boveda S, Dagres N, Di Toro D, Eckhardt LL, Ellenbogen K, Hardy C, Ikeda T, Jaswal A, Kaufman E, Krahn A, Kusano K, Kutyifa V, Lim HS, Lip GYH, Nava-Townsend S, Pak HN, Diez GR, Sauer W, Saxena A, Svendsen JH, Vanegas D, Vaseghi M, Wilde A, Bunch TJ, ESC Scientific Document Group., Buxton AE, Calvimontes G, Chao TF, Eckardt L, Estner H, Gillis AM, Isa R, Kautzner J, Maury P, Moss JD, Nam GB, Olshansky B, Pava Molano LF, Pimentel M, Prabhu M, Tzou WS, Sommer P, Swampillai J, Vidal A, Deneke T, Hindricks G, Leclercq (2020). European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population. Heart rhythm, 17(9), e269-e316.
4. Nielsen JC, Lin YJ, de Oliveira Figueiredo MJ, Sepehri Shamloo A, Alfie A, Boveda S, Dagres N, Di Toro D, Eckhardt LL, Ellenbogen K, Hardy C, Ikeda T, Jaswal A, Kaufman E, Krahn A, Kusano K, Kutyifa V, Lim HS, Lip GYH, Nava-Townsend S, Pak HN, Rodríguez Diez G, Sauer W, Saxena A, Svendsen JH, Vanegas D, Vaseghi M, Wilde A, Bunch TJ, ESC Scientific Document Group., Buxton AE, Calvimontes G, Chao TF, Eckardt L, Estner H, Gillis AM, Isa R, Kautzner J, Maury P, Moss JD, Nam GB, Olshansky B, Pava Molano LF, Pimentel M, Prabhu M, Tzou WS, Sommer P, Swampillai J, Vidal A, Deneke T, Hindricks G, Leclercq (2020). European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population. Europace, 22(8), 1147-1148.
5. Bunch TJ, May HT, Bair TL, Crandall BG, Cutler MJ, Mallender C, Weiss JP, Osborn JS, Day J (2020). Long-term outcomes after low power, slower movement versus high power, faster movement irrigated-tip catheter ablation for atrial fibrillation. Heart rhythm, 17(2), 184-189.
6. Natale A, Mohanty S, Liu PY, Mittal S, Al-Ahmad A, De Lurgio DB, Horton R, Spear W, Bailey S, Bunch J, Musat D, O'Neill P, Compton S, Turakhia MP, AMBULATE Trial Investigators (2020). Venous Vascular Closure System Versus Manual Compression Following Multiple Access Electrophysiology Procedures: The AMBULATE Trial. JACC. Clinical electrophysiology, 6(1), 111-124.
7. Regouski M, Galenko O, Doleac J, Olsen AL, Jacobs V, Liechty D, White KL, Bunch TJ, Lee PM, Rutigliano HM, Polejaeva IA, Cutler M (2019). Spontaneous Atrial Fibrillation in Transgenic Goats With TGF (Transforming Growth Factor)-ß1 Induced Atrial Myopathy With Endurance Exercise. Circulation. Arrhythmia and electrophysiology, 12(11), e007499.
8. Ng R, Manring H, Papoutsidakis N, Albertelli T, Tsai N, See CJ, Li X, Park J, Stevens TL, Bobbili PJ, Riaz M, Ren Y, Stoddard CE, Janssen PM, Bunch TJ, Hall SP, Lo YC, Jacoby DL, Qyang Y, Wright N, Ackermann MA, Campbell S (2019). Patient mutations linked to arrhythmogenic cardiomyopathy enhance calpain-mediated desmoplakin degradation. JCI insight, 5,

News

• Pay attention to your heartbeat! Here are the signs you might be dealing with AFib
• You’ve heard of it, but what causes it? Here’s what to know about atrial fibrillation…

Podcasts

• What Is Atrial Fibrillation and What Treatments Are Available?
• How Cardiac Ablation Can Treat Severe Cases of Atrial Fibrillation